Advertisements


Interpace Diagnostics: Assessing The Fundamentals Of A Growth Bioscience

Interpace Diagnostics: Assessing The Fundamentals Of A Growth Bioscience.....»»

Category: topSource: seekingalphaApr 22nd, 2018

Interpace Biosciences CEO Jack Stover On Diagnostics Business: "Much Of The Growth Opportunity Is Around Awareness"

Interpace Biosciences (NASDAQ: .....»»

Category: blogSource: benzingaApr 1st, 2020

Harvard Bioscience now sees FY21 revenue growth of 10%-14%, consensus $112M

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 6th, 2021

Durham diagnostics firm expects rapid Covid detection test to propel growth

The Durham company is shipping out its first devices allowing for rapid detection of the novel coronavirus – in 17 minutes......»»

Category: topSource: bizjournalsApr 7th, 2021

ViaSat VS-3 Satellite Launch Positions Company For Robust Growth, Says Analyst

While fundamentals remain strong across segments, ViaSat, Inc. (NASDAQ: VSAT) appears positioned for robust growth with the launch of the VS-3 constellation, according to Raymond James. .....»»

Category: blogSource: benzingaApr 1st, 2021

How to Value Costco Stock

Costco Wholesale Corporation (NASDAQ:COST) runs one of the highest quality businesses in the world. It has solid fundamentals, stellar management, excellent growth prospects, and most import.....»»

Category: blogSource: valuewalkMar 9th, 2021

PepsiCo chooses e.fundamentals to power its ecommerce growth in Europe

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 17th, 2021

Interpace Bioscience started at buy with $12 stock price target at Janney

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 15th, 2020

The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics

Zacks.....»»

Category: topSource: redinewsMar 24th, 2020

Interpace Diagnostics announces contract with BCBS of Massachusetts

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 10th, 2020

13 Diagnostics & Research Stocks Moving In Tuesday"s Session

  Gainers • Interpace Bioscienc.....»»

Category: blogSource: benzingaJan 28th, 2020

Hedge Funds Are Warming Up To Aytu BioScience, Inc. (AYTU)

“Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn’t by muc.....»»

Category: topSource: insidermonkeyDec 21st, 2019

Interpace Diagnostics Group, Inc. (IDXG) CEO Jack Stover on Q3 2019 Results - Earnings Call Transcript

Interpace Diagnostics Group, Inc. (IDXG) CEO Jack Stover on Q3 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 13th, 2019

Interpace Diagnostics changes name to Interpace Biosciences

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 13th, 2019

Interpace Diagnostics sees 2020 revenue $50M, consensus $52.44M

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 13th, 2019

Interpace Diagnostics lowers 2019 revenue view to $28M-$32M from $33M-$36M

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 13th, 2019

Interpace Diagnostics reports Q3 EPS (19c), consensus (19c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 13th, 2019

BMW: Solid Fundamentals And Future Plans Deliver More Growth

BMW: Solid Fundamentals And Future Plans Deliver More Growth.....»»

Category: topSource: seekingalphaNov 11th, 2019

Our Toll-Bridge Picks: Strong Fundamentals, Durable Competitive Advantage, Decent Growth Prospects

Our Toll-Bridge Picks: Strong Fundamentals, Durable Competitive Advantage, Decent Growth Prospects.....»»

Category: topSource: seekingalphaNov 3rd, 2019

Eventbrite: Fundamentals Are Improving, But Higher Growth Is Needed

Eventbrite: Fundamentals Are Improving, But Higher Growth Is Needed.....»»

Category: topSource: seekingalphaOct 25th, 2019

NextEra Energy: Constructive Overseers, EPS And Dividend Growth, And Superior Fundamentals

NextEra Energy: Constructive Overseers, EPS And Dividend Growth, And Superior Fundamentals.....»»

Category: topSource: seekingalphaOct 18th, 2019